You just read:

GW Pharmaceuticals and its U.S. Subsidiary Greenwich Biosciences Announce Publication of Landmark Epidiolex® (Cannabidiol) Study in The Lancet

News provided by

GW Pharmaceuticals

24 Jan, 2018, 23:30 GMT